Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherPDA Paper

Points to Consider: Best Practices to Identify Particle Entry Routes Along the Manufacturing Process for Parenteral Formulations

Amy K Stanton
PDA Journal of Pharmaceutical Science and Technology August 2019, pdajpst.2019.010645; DOI: https://doi.org/10.5731/pdajpst.2019.010645
Amy K Stanton
Amgen Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: amgonzal@amgen.com
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2019.010645
DOI 
https://doi.org/10.5731/pdajpst.2019.010645
PubMed 
31420504

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received July 24, 2019
  • Accepted August 13, 2019
  • Published online August 16, 2019.

Article Versions

  • You are currently viewing a previous version of this article (August 16, 2019 - 04:26).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2019, Parenteral Drug Association

Author Information

  1. Amy K Stanton1 (amgonzal{at}amgen.com)
  1. Amgen Inc.
  1. ↵* Corresponding author; email: amgonzal{at}amgen.com

Cited By...

  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Particulates are everywhere, but are they harmful in cell and gene therapies?
    Samuel A. Molina, Stephanie J. Davies, Dalip Sethi, Steve Oh, Nisha Durand, Michael Scott, Lindsay C. Davies, Klaus Wormuth, Dominic Clarke
    Cytotherapy 2022 24 12
  • Impact of vial quality on interactions, particle formation, container closure integrity, and gas permeability for frozen drug product storage
    Daniela Henle, Lukas Muehlfeld, Daniel Molnar, Patrick Garidel, Wolfgang Friess
    European Journal of Pharmaceutical Sciences 2025 206
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 1
January/February 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Points to Consider: Best Practices to Identify Particle Entry Routes Along the Manufacturing Process for Parenteral Formulations
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Points to Consider: Best Practices to Identify Particle Entry Routes Along the Manufacturing Process for Parenteral Formulations
Amy K Stanton
PDA Journal of Pharmaceutical Science and Technology Aug 2019, pdajpst.2019.010645; DOI: 10.5731/pdajpst.2019.010645

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Points to Consider: Best Practices to Identify Particle Entry Routes Along the Manufacturing Process for Parenteral Formulations
Amy K Stanton
PDA Journal of Pharmaceutical Science and Technology Aug 2019, pdajpst.2019.010645; DOI: 10.5731/pdajpst.2019.010645
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Identification and Root Cause Analysis of the Visible Particles Commonly Encountered in the Biopharmaceutical Industry
  • Google Scholar

More in this TOC Section

  • Case Studies on Changes and Proposed Process Development Approaches Reflecting Applicability of PDA Technical Report No. 89: Strategies for Vaccine Development and Lifecycle Management
  • Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review
  • Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic
Show more PDA Paper

Similar Articles

Keywords

  • Elastomer
  • FMEA
  • Glass
  • Particle
  • Visible Particle

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire